Cargando…

The Activity and Safety of Anlotinib for Patients with Extremity Desmoid Fibromatosis: A Retrospective Study in a Single Institution

PURPOSE: Desmoid fibromatosis (DF) is an aggressive fibroblastic neoplasm with a high propensity for local recurrence. Although multiple therapeutic modalities seem effective for DF, the standard systemic treatment for symptomatic and progressive DF remains controversial. As targeted therapy, tyrosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Chuanxi, Zhou, Yong, Wang, Yitian, Luo, Yi, Tu, Chongqi, Min, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524188/
https://www.ncbi.nlm.nih.gov/pubmed/33061299
http://dx.doi.org/10.2147/DDDT.S271008